Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (321-330 of 868) with videos related to

Pageof 87
Sort By:
Blood|July 16, 2016
Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implicationGang An, Chirag Acharya, Xiaoyan Feng, et al.
Experimental Hematology|June 26, 2007
Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma modelLaurence Catley, Teru Hideshima, Dharminder Chauhan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 2009
Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myelomaBrenda M Birmann, Rulla M Tamimi, Edward Giovannucci, et al.
Nature Methods|April 23, 2005
Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomibCelia R Berkers, Martijn Verdoes, Eben Lichtman, et al.
The New England Journal of Medicine|June 12, 2024
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyMetin Ozdemirli, Thomas M Loughney, Emre Deniz, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2026
The International Myeloma Society Honors the Life and Legacy of Myeloma Pioneer Brian G. M. Durie, MD, PhD (1942-2025)Philippe Moreau, Shaji Kumar, Noopur S Raje, et al.
Oncogene|November 25, 2003
Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myelomaTeru Hideshima, Dharminder Chauhan, Toshiaki Hayashi, et al.
Blood|September 18, 2012
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cellsZe Tian, Jian-jun Zhao, Yu-Tzu Tai, et al.
Blood|August 27, 2020
The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implicationsDaisuke Ogiya, Jiye Liu, Hiroto Ohguchi, et al.
Blood|October 1, 2008
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3Erik A Nelson, Sarah R Walker, Alicia Kepich, et al.
Pageof 87

Showing results (321-330 of 868) with videos related to

Sort By:
Pageof 87
Blood|July 16, 2016
Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implicationGang An, Chirag Acharya, Xiaoyan Feng, et al.
Experimental Hematology|June 26, 2007
Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma modelLaurence Catley, Teru Hideshima, Dharminder Chauhan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 2009
Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myelomaBrenda M Birmann, Rulla M Tamimi, Edward Giovannucci, et al.
Nature Methods|April 23, 2005
Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomibCelia R Berkers, Martijn Verdoes, Eben Lichtman, et al.
The New England Journal of Medicine|June 12, 2024
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyMetin Ozdemirli, Thomas M Loughney, Emre Deniz, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2026
The International Myeloma Society Honors the Life and Legacy of Myeloma Pioneer Brian G. M. Durie, MD, PhD (1942-2025)Philippe Moreau, Shaji Kumar, Noopur S Raje, et al.
Oncogene|November 25, 2003
Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myelomaTeru Hideshima, Dharminder Chauhan, Toshiaki Hayashi, et al.
Blood|September 18, 2012
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cellsZe Tian, Jian-jun Zhao, Yu-Tzu Tai, et al.
Blood|August 27, 2020
The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implicationsDaisuke Ogiya, Jiye Liu, Hiroto Ohguchi, et al.
Blood|October 1, 2008
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3Erik A Nelson, Sarah R Walker, Alicia Kepich, et al.
Pageof 87